1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for 'CFS'.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 5th May 2025 is here.
    Dismiss Notice
  3. Welcome! Read the Core Purpose and Values of our forum.
    Dismiss Notice

Epidemics (including Covid-19, not Long Covid)

Discussion of epidemics including Covid-19

Page 22 of 29
Sort By:
Title Start Date
Replies Views
Last Message ↑
  1. EndME

    Comparison of semen parameters in the same patients before and after diagnosis of COVID-19, 2023, Cakir

    EndME, Sep 12, 2023
    Replies:
    1
    Views:
    643
    rvallee
    Sep 12, 2023
  2. EndME

    Identification of new drugs to counteract anti-spike IgG-induced hyperinflammation in severe COVID-19, 2023, Geyer et al

    EndME, Sep 13, 2023
    Replies:
    1
    Views:
    739
    EndME
    Sep 13, 2023
  3. SNT Gatchaman

    [Preprint] Identification of a Druggable Site on GRP78 at the GRP78-SARS-CoV-2 Interface and Compounds to Disrupt that Interface, 2023, Lazou et al.

    SNT Gatchaman, Sep 15, 2023
    Replies:
    0
    Views:
    649
    SNT Gatchaman
    Sep 15, 2023
  4. Mij

    TMPRSS2 activation of Omicron lineage Spike glycoproteins is regulated by TMPRSS2 cleavage of ACE2, 2023, Anupriya Aggarwal et al

    Mij, Sep 23, 2023
    Replies:
    1
    Views:
    521
    Mij
    Sep 23, 2023
  5. Dakota15

    USA - NIH: Clinical trial to test immune modulation strategy for hospitalized covid-19 patients begins, Sept 2023

    Dakota15, Sep 24, 2023
    Replies:
    0
    Views:
    498
    Dakota15
    Sep 24, 2023
  6. Sly Saint

    A brief overview of SARS-CoV-2 infection and its management strategies: a recent update 2023, Das et al

    Sly Saint, Sep 25, 2023
    Replies:
    2
    Views:
    593
    rvallee
    Sep 25, 2023
  7. Andy

    Nature article: COVID vaccines linked to unexpected vaginal bleeding

    Andy, Sep 26, 2023
    Replies:
    2
    Views:
    715
    SNT Gatchaman
    Sep 27, 2023
  8. SNT Gatchaman

    A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes, 2023, Sanderson et al.

    SNT Gatchaman, Sep 27, 2023
    Replies:
    2
    Views:
    563
    Dolphin
    Sep 27, 2023
  9. SNT Gatchaman

    [Preprint] Metabolic and mitochondria alterations induced by SARS-CoV-2 accessory proteins ORF3a, ORF9b, ORF9c and ORF10, 2023, Lopez-Ayllon et al.

    SNT Gatchaman, Sep 27, 2023
    Replies:
    0
    Views:
    565
    SNT Gatchaman
    Sep 27, 2023
  10. Mij

    The New Normal: Delayed Peak SARS-CoV-2 Viral Loads Relative to Symptom Onset and Implications for COVID-19 Testing Programs

    Mij, Sep 29, 2023
    Replies:
    0
    Views:
    516
    Mij
    Sep 29, 2023
  11. Mij

    Nirmatrelvir-Ritonavir and COVID-19 Mortality and Hospitalization Among Patients With Vulnerability to COVID-19 Complications, 2023, Colin R. Dormuth

    Mij, Oct 2, 2023
    Replies:
    0
    Views:
    424
    Mij
    Oct 2, 2023
  12. Sly Saint

    Chronic Fatigue and Dis-Autonomy following COVID-19 Vaccination is Distinguished from Normal Vaccination Response by Altered Blood Markers 2023

    Sly Saint, Oct 3, 2023
    Replies:
    1
    Views:
    624
    SNT Gatchaman
    Oct 3, 2023
  13. Sly Saint

    Inhalation of ACE2 as a therapeutic target on sex-bias differences in SARS-CoV-2 infection and variant of concern, 2023

    Sly Saint, Oct 4, 2023
    Replies:
    2
    Views:
    650
    Amw66
    Oct 5, 2023
  14. SNT Gatchaman

    Computer Weekly: Top science journal faced secret attacks from Covid conspiracy theory group

    SNT Gatchaman, Oct 4, 2023
    Replies:
    1
    Views:
    696
    ukxmrv
    Oct 5, 2023
  15. Mij

    Impact of COVID-19 on Physical Fitness in Central Indian Athletes Aged 20-30 Years: A Cross-Sectional Pilot Study, 2023, Nitin B. Dhokane et al

    Mij, Oct 5, 2023
    Replies:
    0
    Views:
    599
    Mij
    Oct 5, 2023
  16. EndME

    Complement factor D targeting protects endotheliopathy in organoid and monkey models of COVID-19, 2023, Kawakami et al

    EndME, Oct 5, 2023
    Replies:
    0
    Views:
    564
    EndME
    Oct 5, 2023
  17. Mij

    Viral kinetics of sequential SARS-CoV-2 infections, 2023, Stephen M. Kissler et al

    Mij, Oct 6, 2023
    Replies:
    0
    Views:
    493
    Mij
    Oct 6, 2023
  18. SNT Gatchaman

    A myeloid program associated with COVID-19 severity is decreased by therapeutic blockade of IL-6 signaling, 2023, Hackney et al.

    SNT Gatchaman, Oct 11, 2023
    Replies:
    3
    Views:
    632
    SNT Gatchaman
    Oct 11, 2023
  19. SNT Gatchaman

    [Preprint] Longitudinal viscosity of blood plasma for rapid COVID-19 prognostics, 2023, Illibauer et al.

    SNT Gatchaman, Oct 17, 2023
    Replies:
    2
    Views:
    736
    SNT Gatchaman
    Oct 17, 2023
  20. Amw66

    Population immunity predicts evolutionary trajectories of SARS-CoV-2

    Amw66, Oct 25, 2023
    Replies:
    0
    Views:
    528
    Amw66
    Oct 25, 2023
Showing threads 421 to 440 of 572

Thread Display Options

Loading...
Page 22 of 29